Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 170   

Articles published

AZN 4,885.78 +117.28 (2.46%)
price chart
Bernstein ups stance on AstraZeneca to 'outperform', citing big pipeline ...
US broker Bernstein has upped its stance on AstraZeneca PLC (LON:AZN) to 'outperform' from 'market perform, citing the drug maker's big pipeline and takeover possibilities.
4 Reasons To Buy, 2 Controversies Surrounding AstraZeneca  Benzinga
AstraZeneca gains after reporting positive results from two trials of lung ...
Pharmaceuticals company AstraZeneca PLC (LON:AZN) shares rose after saying it has achieved positive results from two separate phase III trials of lung cancer drugs Imfinzi and Tagrisso.
AstraZeneca, Merck and Inctye show cancer treatment advances  Financial Times
AstraZeneca: Positive results in 2 cancer trials  MarketWatch
AstraZeneca offloads remaining rights to anaesthetic portfolio to Aspen for US ...
Drugs giant AstraZeneca PLC (LON:AZN) has agreed to offload the remaining rights to its anaesthetic medicines to a division of Aspen Group for up to US$766mln.
Aspen buys remaining AstraZeneca anesthetic rights  MarketWatch
AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs  Nasdaq
Natixis upgrades AstraZeneca to 'buy' on prospect of positive results from key ...
French broker Natixis has upgraded its rating for AstraZeneca PLC (LON:AZN) to 'buy' from 'neutral' as its analysts feel the prospect of positive results from the group's key MYSTIC lung cancer trial gives the blue chip drugmaker “an asymmetric risk ...
High-Yield Dividend Stock to Target:: AstraZeneca PLC (AZN)  Voice Of Analysts
Astrazeneca PLC (AZN) Receives New Coverage from Analysts at BMO Capital Markets  The Ledger Gazette
AstraZeneca gets regulatory green light for breast cancer drug
Some good news for AstraZeneca PLC (LON:AZN), which said the US Food and Drug Administration (FDA) has approved Faslodex for wider use in women with breast cancer.
AstraZeneca plc (AZN) Rating Reiterated by Citigroup Inc.
AstraZeneca plc (LON:AZN)'s stock had its “buy” rating restated by analysts at Citigroup Inc. in a report issued on Thursday, September 7th, MarketBeat reports.
Bernstein Boosts Rating On Astrazeneca PLC (AZN) To "Outperform"  ExpressNewsline
Tale of the Tape: AstraZeneca PLC (NYSE:AZN) Moves 4.37%  Concord Register
AstraZeneca shares advance on positive lung drug results
Drug maker AstraZeneca Plc (LON:AZN) was boosted, with shares up more than 2%, as it revealed positive test results allowing it to advance a lung disease treatment towards US FDA approval in the first half of 2018.
Are these 5 stocks worth buying today? Carillion plc, AstraZeneca plc, Taylor ...
Should I add these 5 shares to my portfolio? Carillion plc (LON:CLLN) (CLLN.L), AstraZeneca plc (LON:AZN) (AZN.L), Taylor Wimpey plc (LON:TW) (TW.
Barclays PLC Analysts Give AstraZeneca plc (AZN) a GBX 6300 Price Target  The Ledger Gazette
Analysts Suggest There's Still Momentum for ConocoPhillips (COP ...  Post Analyst
Why I'd ditch this defensive dividend stock to buy AstraZeneca plc
Dairy Crest (LSE: DCG) today reported a “strong first half of the year” in a pre-close trading update for the six months to 30 September.
AstraZeneca climbs as Bernstein backs takeover talk
AstraZeneca led the FTSE 100 higher on Friday after Bernstein Research said investors were wrong to write off the chances of another takeover approach.